• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺癌的预防与基因检测:医疗决策的差异

Prevention and genetic testing for breast cancer: variations in medical decisions.

作者信息

Bouchard Louise, Blancquaert I, Eisinger F, Foulkes W D, Evans G, Sobol H, Julian-Reynier C

机构信息

Sociology and Population Health Institute, University of Ottawa, 1 Stewart, Ottawa, ON, Canada K1N 6N5.

出版信息

Soc Sci Med. 2004 Mar;58(6):1085-96. doi: 10.1016/s0277-9536(03)00263-6.

DOI:10.1016/s0277-9536(03)00263-6
PMID:14723904
Abstract

The discovery linking the genes BRCA1&2 to familial breast cancer played an important role in the clinical practice of geneticists and physicians. The availability of genetic tests for BRCA gene mutations prompted cancer geneticists to give information about genetic risk and to assess many women with a personal or family history of breast or ovarian cancer to inform them of preventive measures. These consist mainly of breast self-examination, mammography screening, chemoprevention and prophylactic surgery (mastectomy, oophorectomy). This paper examines clinical practices related to hereditary breast cancer testing and introduces a number of results from a survey carried out, between 1996 and 1998, in three clinics located in Montreal (Quebec, Canada), Marseilles (France) and Manchester (Great Britain). Results show substantial differences in the way cancer geneticists deal with environmental risk factors, breast and ovarian cancer testing, and chemoprevention and prophylactic surgery. Differences across cities persist in the multivariate analysis, suggesting that attitudes towards preventive measures may be partially explained by cultural factors. Different dimensions of culture are discussed including the social representation of health and risk, the interpretation of scientific evidence and the role of innovation leadership.

摘要

将基因BRCA1和BRCA2与家族性乳腺癌联系起来的这一发现,在遗传学家和医生的临床实践中发挥了重要作用。BRCA基因突变基因检测的出现,促使癌症遗传学家提供有关遗传风险的信息,并对许多有个人或家族乳腺癌或卵巢癌病史的女性进行评估,以便告知她们预防措施。这些措施主要包括乳房自我检查、乳房X光筛查、化学预防和预防性手术(乳房切除术、卵巢切除术)。本文研究了与遗传性乳腺癌检测相关的临床实践,并介绍了1996年至1998年期间在位于加拿大魁北克省蒙特利尔、法国马赛和英国曼彻斯特的三家诊所进行的一项调查的一些结果。结果显示,癌症遗传学家在处理环境风险因素、乳腺癌和卵巢癌检测以及化学预防和预防性手术的方式上存在显著差异。在多变量分析中,不同城市之间的差异依然存在,这表明对预防措施的态度可能部分由文化因素解释。文中讨论了文化的不同维度,包括健康和风险的社会表征、科学证据的解释以及创新领导力的作用。

相似文献

1
Prevention and genetic testing for breast cancer: variations in medical decisions.乳腺癌的预防与基因检测:医疗决策的差异
Soc Sci Med. 2004 Mar;58(6):1085-96. doi: 10.1016/s0277-9536(03)00263-6.
2
Women's attitudes toward preventive strategies for hereditary breast or ovarian carcinoma differ from one country to another: differences among English, French, and Canadian women.不同国家的女性对遗传性乳腺癌或卵巢癌预防策略的态度存在差异:英国、法国和加拿大女性之间的差异。
Cancer. 2001 Aug 15;92(4):959-68. doi: 10.1002/1097-0142(20010815)92:4<959::aid-cncr1406>3.0.co;2-v.
3
Prevention and therapy for BRCA1/2 mutation carriers and women at high risk for breast and ovarian cancer.BRCA1/2 基因突变携带者以及乳腺癌和卵巢癌高危女性的预防与治疗。
Eur J Cancer Prev. 2000 Jun;9(3):139-50.
4
International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers.携带BRCA1和BRCA2基因突变者预防性治疗方案的国际应用率差异
Int J Cancer. 2008 May 1;122(9):2017-22. doi: 10.1002/ijc.23340.
5
Association between clinical characteristics and risk-reduction interventions in women who underwent BRCA1 and BRCA2 testing: a single-institution study.接受BRCA1和BRCA2检测的女性临床特征与风险降低干预措施之间的关联:一项单机构研究。
Cancer. 2006 Dec 15;107(12):2745-51. doi: 10.1002/cncr.22352.
6
Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: US Preventive Services Task Force Recommendation Statement.BRCA 相关癌症的风险评估、遗传咨询和基因检测:美国预防服务工作组推荐声明。
JAMA. 2019 Aug 20;322(7):652-665. doi: 10.1001/jama.2019.10987.
7
Individualized preventive and therapeutic management of hereditary breast ovarian cancer syndrome.遗传性乳腺癌卵巢癌综合征的个体化预防与治疗管理
Nat Clin Pract Oncol. 2007 Oct;4(10):578-90. doi: 10.1038/ncponc0930.
8
Cancer prevention and screening practices among women at risk for hereditary breast and ovarian cancer after genetic counseling in the community setting.社区环境下遗传咨询后遗传性乳腺癌和卵巢癌高危女性的癌症预防和筛查实践。
Fam Cancer. 2009;8(4):277-87. doi: 10.1007/s10689-009-9242-z. Epub 2009 Apr 4.
9
Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Genetics Studies Consortium.癌症遗传易感性个体的后续护理建议。II. BRCA1和BRCA2。癌症遗传学研究联盟。
JAMA. 1997 Mar 26;277(12):997-1003.
10
Breast cancer and ovarian cancer genetics.乳腺癌与卵巢癌遗传学
J Long Term Eff Med Implants. 2005;15(5):533-45. doi: 10.1615/jlongtermeffmedimplants.v15.i5.60.

引用本文的文献

1
Raman spectromics method for fast and label-free genotype screening.用于快速且无标记基因型筛选的拉曼光谱法。
Biomed Opt Express. 2023 May 31;14(6):3072-3085. doi: 10.1364/BOE.493524. eCollection 2023 Jun 1.
2
Cancer Cell Culture: The Basics and Two-Dimensional Cultures.肿瘤细胞培养:基础与二维培养
Methods Mol Biol. 2023;2645:3-40. doi: 10.1007/978-1-0716-3056-3_1.
3
Time trends in uptake rates of risk-reducing mastectomy in Israeli asymptomatic BRCA1 and BRCA2 mutation carriers.以色列无症状 BRCA1 和 BRCA2 突变携带者中降低风险的乳房切除术接受率的时间趋势。
Breast Cancer Res Treat. 2021 Jan;185(2):391-399. doi: 10.1007/s10549-020-05949-z. Epub 2020 Sep 30.
4
The iPrevent Online Breast Cancer Risk Assessment and Risk Management Tool: Usability and Acceptability Testing.iPrevent在线乳腺癌风险评估与风险管理工具:可用性和可接受性测试
JMIR Form Res. 2018 Nov 7;2(2):e24. doi: 10.2196/formative.9935.
5
Decision making for breast cancer prevention among women at elevated risk.乳腺癌高危女性的预防决策
Breast Cancer Res. 2017 Mar 24;19(1):34. doi: 10.1186/s13058-017-0826-5.
6
Media Exposure and Genetic Literacy Skills to Evaluate Angelina Jolie's Decision for Prophylactic Mastectomy.媒体曝光与评估安吉丽娜·朱莉预防性乳房切除术决策的基因知识技能
Public Health Genomics. 2016;19(5):282-9. doi: 10.1159/000447944. Epub 2016 Jul 19.
7
The knowledge value-chain of genetic counseling for breast cancer: an empirical assessment of prediction and communication processes.乳腺癌遗传咨询的知识价值链:预测与沟通流程的实证评估
Fam Cancer. 2016 Jan;15(1):1-17. doi: 10.1007/s10689-015-9835-7.
8
Psychosocial approaches to participation in BRCA1/2 genetic risk assessment among African American women: a systematic review.非裔美国女性参与BRCA1/2基因风险评估的社会心理方法:一项系统综述
J Community Genet. 2014 Apr;5(2):89-98. doi: 10.1007/s12687-013-0164-y. Epub 2013 Aug 10.
9
Variation in rates of uptake of preventive options by Canadian women carrying the BRCA1 or BRCA2 genetic mutation.携带BRCA1或BRCA2基因突变的加拿大女性对预防性措施的接受率差异。
Open Med. 2007 Aug 13;1(2):e92-8.
10
Agency and choice in genetic counseling: Acknowledging patients' concerns.遗传咨询中的代理与选择:承认患者的担忧。
J Genet Couns. 2009 Oct;18(5):464-74. doi: 10.1007/s10897-009-9237-9.